| Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination RK Suryawanshi, IP Chen, T Ma, AM Syed, N Brazer, P Saldhi, ... Nature 607 (7918), 351-355, 2022 | 200 | 2022 |
| Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles AM Syed, A Ciling, TY Taha, IP Chen, MM Khalid, B Sreekumar, PY Chen, ... Proceedings of the National Academy of Sciences 119 (31), e2200592119, 2022 | 173 | 2022 |
| Studies on Production and Biological Potential of Prodigiosin by Serratia marcescens RK Suryawanshi, CD Patil, HP Borase, BK Salunke, SV Patil Applied biochemistry and biotechnology 173, 1209-1221, 2014 | 113 | 2014 |
| Pathological processes activated by herpes simplex virus-1 (HSV-1) infection in the cornea L Koujah, RK Suryawanshi, D Shukla Cellular and molecular life sciences 76, 405-419, 2019 | 109 | 2019 |
| Towards an understanding of bacterial metabolites prodigiosin and violacein and their potential for use in commercial sunscreens RK Suryawanshi, CD Patil, HP Borase, CP Narkhede, A Stevenson, ... International journal of cosmetic science 37 (1), 98-107, 2015 | 96 | 2015 |
| Antimicrobial activity of prodigiosin is attributable to plasma-membrane damage RK Suryawanshi, CD Patil, SH Koli, JE Hallsworth, SV Patil Natural product research 31 (5), 572-577, 2017 | 95 | 2017 |
| Dysregulation of cell signaling by SARS-CoV-2 RK Suryawanshi, R Koganti, A Agelidis, CD Patil, D Shukla Trends in microbiology 29 (3), 224-237, 2021 | 86 | 2021 |
| Trypsin inactivation by latex fabricated gold nanoparticles: a new strategy towards insect control CD Patil, HP Borase, RK Suryawanshi, SV Patil Enzyme and Microbial Technology 92, 18-25, 2016 | 83 | 2016 |
| In vitro antiparasitic activity of microbial pigments and their combination with phytosynthesized metal nanoparticles S Rahul, P Chandrashekhar, B Hemant, S Bipinchandra, E Mouray, ... Parasitology international 64 (5), 353-356, 2015 | 81 | 2015 |
| Nematicidal activity of microbial pigment from Serratia marcescens SLPS Suryawanshi Rahul, Patil Chandrashekhar, Borase Natural Product Research,, 2014 | 72 | 2014 |
| Mosquito larvicidal and pupaecidal potential of prodigiosin from Serratia marcescens and understanding its mechanism of action RK Suryawanshi, CD Patil, HP Borase, CP Narkhede, BK Salunke, ... Pesticide biochemistry and physiology 123, 49-55, 2015 | 63 | 2015 |
| Drug-encapsulated carbon (DECON): A novel platform for enhanced drug delivery T Yadavalli, J Ames, A Agelidis, R Suryawanshi, D Jaishankar, J Hopkins, ... Science advances 5 (8), eaax0780, 2019 | 60 | 2019 |
| SARS-CoV-2 hybrid immunity: silver bullet or silver lining? R Suryawanshi, M Ott Nature Reviews Immunology 22 (10), 591-592, 2022 | 59 | 2022 |
| Neuropilin-1 mediates SARS-CoV-2 infection of astrocytes in brain organoids, inducing inflammation leading to dysfunction and death of neurons W Kong, M Montano, MJ Corley, E Helmy, H Kobayashi, M Kinisu, ... MBio 13 (6), e02308-22, 2022 | 53 | 2022 |
| Lead optimization at C-2 and N-3 positions of thiazolidin-4-ones as HIV-1 non-nucleoside reverse transcriptase inhibitors V Murugesan, VS Tiwari, R Saxena, R Tripathi, R Paranjape, S Kulkarni, ... Bioorganic & medicinal chemistry 19 (22), 6919-6926, 2011 | 51 | 2011 |
| Heparanase, cell signaling, and viral infections R Koganti, R Suryawanshi, D Shukla Cellular and Molecular Life Sciences 77, 5059-5077, 2020 | 48 | 2020 |
| An intra-vaginal zinc oxide tetrapod nanoparticles (ZOTEN) and genital herpesvirus cocktail can provide a novel platform for live virus vaccine A Agelidis, L Koujah, R Suryawanshi, T Yadavalli, YK Mishra, R Adelung, ... Frontiers in immunology 10, 500, 2019 | 48 | 2019 |
| Evaluation of 4-thiazolidinone derivatives as potential reverse transcriptase inhibitors against HIV-1 drug resistant strains R Suryawanshi, S Jadhav, N Makwana, D Desai, D Chaturbhuj, ... Bioorganic Chemistry 71, 211-218, 2017 | 48 | 2017 |
| Mechanistic approach for fabrication of gold nanoparticles by Nitzschia diatom and their antibacterial activity HP Borase, CD Patil, RK Suryawanshi, SH Koli, BV Mohite, G Benelli, ... Bioprocess and Biosystems Engineering 40, 1437-1446, 2017 | 46 | 2017 |
| Rational design and synthesis of novel thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors V Murugesan, N Makwana, R Suryawanshi, R Saxena, R Tripathi, ... Bioorganic & medicinal chemistry 22 (12), 3159-3170, 2014 | 43 | 2014 |
Chandrashekhar D. PatilDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago在 uic.edu 的电子邮件经过验证
